UPDATED Apr 23, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$407.57 | -1.0% | 38.0% | US$3.0t | US$471.24 | PE36.7x | E12.6% | 0.7% | Software | ||
GOOGL | US$158.26 | 1.8% | 52.6% | US$2.0t | US$166.83 | PE26.7x | E11.8% | n/a | Media | ||
AMZN | US$179.54 | -1.0% | 71.0% | US$1.9t | US$209.60 | PE61.4x | E21.6% | n/a | Retail | ||
META | US$496.10 | 0.4% | 136.9% | US$1.3t | US$541.20 | PE32.2x | E14.4% | 0.4% | Media | ||
LLY | US$745.69 | -0.7% | 98.2% | US$671.7b | US$813.32 | PE128.2x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$783.00 | -2.6% | 59.3% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,249.19 | -2.6% | 102.7% | US$578.9b | US$1,500.96 | PE50x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.878.70 | 0.8% | 58.2% | kr.4.0t | kr.904.20 | PE46.8x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$192.14 | 6.7% | 42.1% | US$551.8b | US$205.53 | PB1.8x | E-1.7% | 2.4% | Banks | ||
XOM | US$121.03 | 2.0% | 4.8% | US$479.1b | US$129.81 | PE13.3x | E-0.6% | 3.1% | Energy | ||
WMT | US$59.09 | -0.9% | 17.5% | US$476.2b | US$65.08 | PE30.7x | E10.7% | 1.4% | Consumer Retailing | ||
UNH | US$486.18 | 1.5% | 0.7% | US$447.3b | US$568.86 | PE29.1x | E19.7% | 1.5% | Healthcare | ||
700 | HK$344.20 | 14.4% | -1.1% | HK$3.2t | HK$417.73 | PE25.7x | E15.0% | 1.0% | Media | ||
PG | US$161.50 | 2.9% | 4.5% | US$381.2b | US$169.90 | PE25.7x | E6.8% | 2.3% | Household | ||
A005930 | ₩78,600.00 | -0.4% | 22.6% | ₩523.0t | ₩101,991.89 | PE36.9x | E27.4% | 1.8% | Tech | ||
JNJ | US$149.56 | 3.3% | -8.0% | US$360.4b | US$173.60 | PE18.8x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$339.00 | 1.9% | 17.7% | US$336.0b | US$384.83 | PE22.2x | E4.2% | 2.7% | Retail | ||
MRK | US$126.88 | 1.2% | 11.9% | US$321.4b | US$137.58 | PE880.5x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$722.68 | 1.0% | 46.1% | US$320.5b | US$776.41 | PE47.2x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$115.09 | -3.0% | 22.8% | US$316.3b | US$137.02 | PE29.7x | E14.7% | 1.4% | Software | ||
BAC | US$38.37 | 8.9% | 34.9% | US$301.9b | US$39.52 | PB1.1x | E6.2% | 2.5% | Banks | ||
CVX | US$162.85 | 4.1% | -1.9% | US$300.8b | US$181.37 | PE14.1x | E2.3% | 4.0% | Energy | ||
ABBV | US$169.54 | 3.2% | 4.8% | US$300.2b | US$184.14 | PE62.3x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
600519 | CN¥1,693.60 | 1.6% | -2.9% | CN¥2.1t | CN¥2,154.31 | PE28.5x | E12.8% | 3.0% | Food, Beverage & Tobacco |